Brief: Newbury Pharmaceuticals Q2 EBITDA Loss SEK 1 Mln
April 9 (Reuters) - Newbury Pharmaceuticals AB NEWBRY.ST: Q2 EBITDA SEK -1 MILLION Q2 REVENUE SEK 3 MILLION Source text: ID:nMFN8JCGWX Further company coverage: NEWBRY.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln